Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

SLS

SELLAS Life Sciences Group Inc

Apr 29 • 12:55PM ET

4.82

-0.07 -1.33 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: TGTX KPTI IMMP AFMD ADAP BCRX ACET AVDL TLSA

| Held by: XBI VTI IWM VXF IWO VTWO VFMO IWC PTH DWAS

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.25	Insider Own	1.27%	Shs Outstand	179.58M	Perf Week	0.73%
Market Cap	864.69M	Forward P/E	-	EPS next Y	-0.16	Insider Trans	2.86%	Shs Float	177.31M	Perf Month	20.22%
Enterprise Value	793.80M	PEG	-	EPS next Q	-0.06	Inst Own	24.08%	Short Float	31.95%	Perf Quarter	21.44%
Income	-26.86M	P/S	-	EPS this Y	-12.00%	Inst Trans	1.19%	Short Ratio	8.92	Perf Half Y	148.20%
Sales	0.00M	P/B	10.40	EPS next Y	42.86%	ROA	-54.84%	Short Interest	56.64M	Perf YTD	27.72%
Book/sh	0.46	P/C	12.03	EPS next 5Y	-	ROE	-66.88%	52W High	6.14 -21.58%	Perf Year	236.71%
Cash/sh	0.40	P/FCF	-	EPS past 3/5Y	51.28% 34.92%	ROIC	-37.66%	52W Low	1.36 254.04%	Perf 3Y	242.70%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	5.86% 6.48%	Perf 5Y	-39.89%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	54.32%	Oper. Margin	-	ATR (14)	0.36	Perf 10Y	-99.99%
Dividend Ex-Date	Mar 24, 2011	Quick Ratio	10.72	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	50.33	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	10.72	EPS Q/Q	45.12%	SMA20	1.15%	Beta	2.26	Target Price	10.00
Payout	-	Debt/Eq	0.01	Sales Q/Q	-	SMA50	-1.26%	Rel Volume	0.53	Prev Close	4.88
Employees	13	LT Debt/Eq	0.01	Earnings	Mar 19 AMC	SMA200	63.72%	Avg Volume	6.35M	Price	4.82
IPO	Mar 12, 2008	Option/Short	Yes / Yes	EPS/Sales Surpr.	21.01% -	Trades		Volume	1,854,434	Change	-1.33%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)